Literature DB >> 10617208

Inhibition of msl-2 splicing by Sex-lethal reveals interaction between U2AF35 and the 3' splice site AG.

L Merendino1, S Guth, D Bilbao, C Martínez, J Valcárcel.   

Abstract

The protein Sex-lethal (SXL) controls dosage compensation in Drosophila by inhibiting the splicing and translation of male-specific-lethal-2 (msl-2) transcripts. Here we report that splicing inhibition of msl-2 requires a binding site for SXL at the polypyrimidine (poly(Y)) tract associated with the 3' splice site, and an unusually long distance between the poly(Y) tract and the conserved AG dinucleotide at the 3' end of the intron. Only this combination allows efficient blockage of U2 small nuclear ribonucleoprotein particle binding and displacement of the large subunit of the U2 auxiliary factor (U2AF65) from the poly(Y) tract by SXL. Crosslinking experiments with ultraviolet light indicate that the small subunit of U2AF (U2AF35) contacts the AG dinucleotide only when located in proximity to the poly(Y) tract. This interaction stabilizes U2AF65 binding such that SXL can no longer displace it from the poly(Y) tract. Our results reveal a novel function for U2AF35, a critical role for the 3' splice site AG at the earliest steps of spliceosome assembly and the need for a weakened U2AF35-AG interaction to regulate intron removal.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10617208     DOI: 10.1038/45602

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  151 in total

1.  An upstream AG determines whether a downstream AG is selected during catalytic step II of splicing.

Authors:  K Chua; R Reed
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

2.  Role of the 3' splice site in U12-dependent intron splicing.

Authors:  R C Dietrich; M J Peris; A S Seyboldt; R A Padgett
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

3.  Identification of a U2/U6 helix la mutant that influences 3' splice site selection during nuclear pre-mRNA splicing.

Authors:  J S Chang; D S McPheeters
Journal:  RNA       Date:  2000-08       Impact factor: 4.942

4.  Alternative splicing of U12-dependent introns in vivo responds to purine-rich enhancers.

Authors:  R C Dietrich; G C Shukla; J D Fuller; R A Padgett
Journal:  RNA       Date:  2001-10       Impact factor: 4.942

5.  Genetic interactions between the 5' and 3' splice site consensus sequences and U6 snRNA during the second catalytic step of pre-mRNA splicing.

Authors:  C A Collins; C Guthrie
Journal:  RNA       Date:  2001-12       Impact factor: 4.942

Review 6.  RNA-protein interactions that regulate pre-mRNA splicing.

Authors:  Ravinder Singh
Journal:  Gene Expr       Date:  2002

7.  Mutational analysis of a plant branchpoint and polypyrimidine tract required for constitutive splicing of a mini-exon.

Authors:  Craig G Simpson; Graham Thow; Gillian P Clark; S Nikki Jennings; Jenny A Watters; John W S Brown
Journal:  RNA       Date:  2002-01       Impact factor: 4.942

8.  Functional selection of splicing enhancers that stimulate trans-splicing in vitro.

Authors:  L A Boukis; J P Bruzik
Journal:  RNA       Date:  2001-06       Impact factor: 4.942

Review 9.  Sorting out the complexity of SR protein functions.

Authors:  B R Graveley
Journal:  RNA       Date:  2000-09       Impact factor: 4.942

Review 10.  Polypyrimidine tract binding protein antagonizes exon definition.

Authors:  E J Wagner; M A Garcia-Blanco
Journal:  Mol Cell Biol       Date:  2001-05       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.